Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.
Theranostics
; 11(9): 4502-4515, 2021.
Article
in En
| MEDLINE
| ID: mdl-33754074
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Atherosclerosis
/
Sodium-Glucose Transporter 2
/
Sodium-Glucose Transporter 2 Inhibitors
Limits:
Animals
/
Humans
Language:
En
Journal:
Theranostics
Year:
2021
Document type:
Article
Affiliation country: